PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
12 months from date of receipt / reconstitution, -20 °C as supplied
| 应用 | 稀释度 | 推荐种属 |
|---|---|---|
| WB | 1:1000 | Hu |
Interferon regulatory factor 7 (IRF7) is a key transcription factor and a critical regulator of type I interferon (IFN) responses, predominantly expressed in lymphoid tissues such as the spleen, thymus, and peripheral blood lymphocytes. It plays a central role in the innate immune response against viral infections by regulating the transcription of IFN-β and IFN-α genes. IRF7 is activated through various pattern recognition receptors (PRRs) and signaling pathways, including the MyD88-dependent and TRIF-dependent pathways, leading to its phosphorylation, dimerization, and nuclear translocation to induce IFN production. Additionally, IRF7 is involved in the regulation of autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), where its expression and genetic polymorphisms are associated with disease susceptibility. IRF7 also exhibits antiviral and immunomodulatory functions, making it a potential target for therapeutic interventions in viral infections and autoimmune disorders.
WB result of IRF7 Recombinant Rabbit mAb
Primary antibody: IRF7 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated Jurkat whole cell lysate 20 µg
Lane 2: Jurkat treated with 100 nM hIFN-α for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 54 kDa
Observed MW: 65 kDa
您现在的位置：